Hap Trading, LLC Abbott Laboratories Call Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $750,525 - $885,975	-7,500 Reduced 24.51%	23,100 $111 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $3.08 Million - $3.44 Million	30,600 New	30,600 $65.6 Million
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $534,968 - $641,872	5,600 Added 35.0%	21,600 $2.09 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $50,390 - $56,145	-500 Reduced 3.03%	16,000 $1.74 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $658,648 - $775,268	-6,800 Reduced 29.18%	16,500 $40,000
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.21 Million - $1.42 Million	12,700 Added 119.81%	23,300 $84,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $212,872 - $246,466	-2,200 Reduced 17.19%	10,600 $12,000
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $1.7 Million - $2.06 Million	-16,700 Reduced 56.61%	12,800 $20,000
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $399,070 - $486,640	-3,500 Reduced 10.61%	29,500 $43,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $2.2 Million - $2.69 Million	19,000 Added 135.71%	33,000 $533,000
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $524,970 - $580,770	-4,500 Reduced 24.32%	14,000 $117,000
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $158,685 - $186,795	1,500 Added 8.82%	18,500 $130,000
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $3.12 Million - $3.68 Million	-28,700 Reduced 62.8%	17,000 $183,000
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $73,500 - $80,094	700 Added 1.56%	45,700 $307,000
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $1.92 Million - $2.33 Million	20,900 Added 86.72%	45,000 $421,000
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $781,013 - $999,600	-10,200 Reduced 29.74%	24,100 $147,000
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $508,842 - $744,066	8,100 Added 30.92%	34,300 $96,000
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $502,464 - $559,360	6,400 Added 32.32%	26,200 $180,000
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $761,112 - $825,282	-9,300 Reduced 31.96%	19,800 $117,000
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $583,040 - $680,000	8,000 Added 37.91%	29,100 $190,000
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $715,176 - $864,648	-10,800 Reduced 33.86%	21,100 $81,000
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $786,720 - $891,240	12,000 Added 60.3%	31,900 $112,000
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $85,134 - $102,704	-1,400 Reduced 6.57%	19,900 $173,000
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $91,256 - $97,699	1,700 Added 8.67%	21,300 $61,000
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $941,976 - $1.05 Million	19,600	19,600 $51,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.03 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.74 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.28 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account